Literature DB >> 7711582

Surgical bleeding: unexpected effect of a calcium antagonist.

L E Wagenknecht1, C D Furberg, J W Hammon, C Legault, B T Troost.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711582      PMCID: PMC2549165          DOI: 10.1136/bmj.310.6982.776

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

Authors:  S Yusuf; P Held; C Furberg
Journal:  Am J Cardiol       Date:  1991-06-01       Impact factor: 2.778

Review 2.  Bleeding complications associated with cardiopulmonary bypass.

Authors:  R C Woodman; L A Harker
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

Review 3.  Current status of calcium channel blockers.

Authors:  W H Frishman
Journal:  Curr Probl Cardiol       Date:  1994-11       Impact factor: 5.200

4.  Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography.

Authors:  C I Blauth; J V Arnold; W E Schulenberg; A C McCartney; K M Taylor
Journal:  J Thorac Cardiovasc Surg       Date:  1988-04       Impact factor: 5.209

5.  Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration.

Authors:  R C Becker; R Caputo; S Ball; J M Corrao; S Baker; J M Gore
Journal:  Am Heart J       Date:  1993-07       Impact factor: 4.749

6.  Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Authors:  J M Gore; M Sloan; T R Price; A M Randall; E Bovill; D Collen; S Forman; G L Knatterud; G Sopko; M L Terrin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

  6 in total
  16 in total

1.  Surgical bleeding and calcium antagonists. British aneurysm nimodipine trial reported improved clinical outcome with nimodipine.

Authors:  G D Murray
Journal:  BMJ       Date:  1995-08-05

2.  Surgical bleeding and calcium antagonists. Other causes for increased risk of bleeding are possible.

Authors:  N Dorsch; J Van Gelder
Journal:  BMJ       Date:  1995-08-05

3.  Surgical bleeding and calcium antagonists. Incidence of bleeding may be lower than suggested.

Authors:  J Ohman
Journal:  BMJ       Date:  1995-08-05

Review 4.  Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Authors:  M Pahor; C D Furberg
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

Review 5.  Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?

Authors:  D G Beevers; P Sleight
Journal:  BMJ       Date:  1996-05-04

Review 6.  Bioequivalence of controlled-release calcium antagonists.

Authors:  R Schall; F R Müller; F O Müller; H G Luus
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

7.  Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?

Authors:  J A Foley; R C Becker
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

Review 8.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

9.  Surgical bleeding and calcium antagonists.

Authors:  M Hynynen; A Kuitunen; M Salmenpera
Journal:  BMJ       Date:  1996-02-03

10.  Oral administration of cilnidipine to patients with hypertensive intracerebral hemorrhage in the acute stage: significance and role of an N-type calcium channel blocker.

Authors:  A Matsuno; F Ide; H Tanaka; S Asano; S Miyawaki; T Uno; J Tanaka; H Nakaguchi; M Sasaki; M Murakami; N Fuke
Journal:  Ir J Med Sci       Date:  2009-12       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.